IHT Wealth Management’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-1,166
Closed -$248K 864
2020
Q4
$248K Sell
1,166
-3
-0.3% -$598 0.02% 624
2020
Q3
$200K Buy
1,169
+33
+3% +$6.09K 0.02% 605
2020
Q2
$218K Buy
+1,136
New +$186K 0.03% 497
2017
Q3
Sell
-369
Closed -$28 1521
2017
Q2
$28 Hold
369
0.01% 678
2017
Q1
$26K Hold
369
0.02% 583
2016
Q4
$23K Buy
+369
New +$22.6K 0.02% 593

Other funds holding RMD

IHT Wealth Management's RMD Position: Q1 2021 in Review

IHT Wealth Management sold out of ResMed (RMD) in Q1 2021, closing a stake of 1,166 shares — an estimated $248K sold.

IHT Wealth Management first reported a position in RMD in Q4 2016 and held it in 6 quarters. The position peaked at $248K in Q4 2020. 662 funds tracked by Wall St. Rank hold RMD as of Q1 2021.

  • IHT Wealth Management reported no remaining ResMed position as of Q1 2021 after selling out during the quarter.
  • IHT Wealth Management sold 1,166 ResMed shares in Q1 2021, an estimated $248K.
  • IHT Wealth Management first reported a position in ResMed in Q4 2016 and held it in 6 quarters.
  • IHT Wealth Management's ResMed position peaked at $248K in Q4 2020.
  • 662 funds tracked by Wall St. Rank held ResMed as of Q1 2021.

Based on IHT Wealth Management's 13F filing for Q1 2021, filed 18 May 2021.